The First Affiliated Hospital Of Xiamen University
Clinical trials sponsored by The First Affiliated Hospital Of Xiamen University, explained in plain language.
-
New 'Living Drug' trial offers hope for patients with Tough-to-Treat lymphoma
Disease control Recruiting nowThis is an early-stage study testing a new type of personalized cell therapy called GB5005 in adults with a specific type of lymphoma (B-cell non-Hodgkin lymphoma) that has come back or not responded to standard treatments. The main goal is to check the safety and side effects of…
Phase: PHASE1 • Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
New drug cocktail tested for leukemia that Won't quit
Disease control Recruiting nowThis study is testing whether adding a drug called chidamide to a standard two-drug treatment is safe and more effective for adults whose acute myeloid leukemia has come back or hasn't responded to prior therapy. The goal is to see if this three-drug combination can help more pat…
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New scan lights up Hard-to-Find cancer tumors
Diagnosis Recruiting nowThis study is testing a new type of PET scan designed to find neuroendocrine cancer tumors more accurately. The scan uses a special tracer that attaches to a protein called DLL3, which is often found on these cancer cells. Researchers will compare this new scan to standard imagin…
Phase: NA • Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Diagnosis
Last updated Apr 01, 2026 21:56 UTC
-
New scan could sharpen prostate cancer detection
Diagnosis Recruiting nowThis study is testing a new type of PET scan to find prostate cancer tumors. Researchers will compare this new scan, called 68Ga-XACP3 PET/CT, to the current standard scan to see if it's better at spotting cancer. The goal is to improve how doctors detect and locate prostate canc…
Phase: NA • Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Diagnosis
Last updated Mar 18, 2026 14:41 UTC
-
New scan could tell doctors if cancer drug is working sooner
Knowledge-focused Recruiting nowThis study is testing whether a special type of PET/CT scan can predict how well a new targeted drug works for advanced lung cancer. Researchers will give the scan to 50 patients before and during their treatment to see if early scan results match their long-term response. The go…
Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:17 UTC